Scot Pollard has a long family history of heart disease, and he’s been on a watch list for several years now due to his size. He's been in and out of hospitals for more than three years due to an ongoing fight with cardiomyopathy. 

TAVR continues to gain momentum as a go-to treatment option for severe AS, making it more important than ever to investigate long-term outcomes. This latest analysis, published in European Heart Journal, focused on 280 patients randomized to undergo either transcatheter or surgical aortic valve replacement.

Remote monitoring with the Reveal Linq insertable cardiac monitor can improve outcomes without breaking the bank, according to new data being presented at the International Stroke Conference in Phoenix.

One of the world's leading heart hospitals is seeing significant growth. This represents the first time it has hired four new cardiothoracic surgeons in a single 12-month period. 

The company, part of Johnson & Johnson MedTech, shared positive data from two different clinical trials at AF Symposium 2024 in Boston.

Francisco Arabia, MD, spoke with Cardiovascular Business about the present and future of total artificial heart technology.

Researchers are presently tracking the safety and effectiveness of the new device in patients with ADHF compared to diuretics alone. 

Researchers explored the potential of an alternate way to perform PFA on patients with persistent AFib, presenting their findings live at AF Symposium 2024 in Boston.